Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Doctors expect enthusiasm for Allergan's high-flying Zeltiq to fade: survey
Fierce Pharma
Wed, 03/28/18 - 09:34 am
Tags:
Allergan, Zeltiq, physicians
Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink
Xconomy
Mon, 03/26/18 - 09:54 am
Tags:
Allergan, Biohaven Pharmaceuticals, migraines, rimegepant
Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner
Xtalks
Mon, 03/26/18 - 09:36 am
Tags:
Amgen, Allergan, Herceptin, biosimilars, ABP 980, CHMP, EMA, Roche
Allergan - Forest gender discrimination $4 million settlement final date approaching
CP Wire
Thu, 03/22/18 - 03:51 pm
Tags:
Allergan, Forest Labs, gender discrimination, Class Action Lawsuit, settlements
Thu, 03/22/18 - 03:44 pm
Tags:
Allergan, Forest Labs, gender discrimination, Class Action Lawsuit, settlements
Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire
Xtalks
Wed, 03/21/18 - 10:55 am
Tags:
Ocugen, dry eye disease, OCU310, Shire, Allergan, Restasis, Xiidra
Tribe looks to stop patent board’s review of Restasis IP
Drug Delivery Business News
Tue, 03/20/18 - 11:13 am
Tags:
Allergan, Restasis, intellectual property, patents
Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening
Fierce Pharma
Thu, 03/15/18 - 11:22 am
Tags:
Allergan, Pharma CEOs, Brent Saunders, spinoffs
Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package
Endpoints
Wed, 03/14/18 - 11:36 am
Tags:
executive pay, Pharma CEOs, Allergan, Brent Saunders, Alex Gorsky, Richard Gonzalez
Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’
Endpoints
Fri, 03/9/18 - 11:05 am
Tags:
Senate, Allergan, patents, Restasis, inter partes review
U.S. judge says opioid settlement roadblocks may prompt trials
Reuters
Thu, 03/8/18 - 09:45 am
Tags:
opioids, opioid crisis, JNJ, Purdue Pharma, Allergan, Endo International, Teva Pharmaceutical
Botox Biosimilar in Development by Mylan and Revance Therapeutics
Xtalks
Mon, 03/5/18 - 11:10 am
Tags:
Botox, Allergan, biosimilars, Mylan Labs, Revance Therapeutics
Top 5 viewed boards for week ending March 3, 2018
CP Wire
Sun, 03/4/18 - 01:50 pm
Tags:
cafepharma, Daiichi Sankyo, Shire, Allergan, Amgen, Sanofi, sales meeting, layoffs, Esmya, Pfizer, Celgene, M&A
FDA pushes back PDUFA date on Allergan’s uterine fibroid drug
Fierce Biotech
Thu, 03/1/18 - 10:02 am
Tags:
FDA, Allergan, uterine fibroids, ulipristal acetate
Pfizer, Roche and Allergan Weigh FDA Plans for Patient-Focused Drug Development Guidance
RAPS.org
Tue, 02/27/18 - 10:40 pm
Tags:
Pfizer, Roche, Allergan, FDA, patients, drug development
Sovereign nonsense: Patent board joins the lineup of critics dissing Allergan’s ‘illusory’ IP deal with the Mohawks
Endpoints
Mon, 02/26/18 - 11:04 pm
Tags:
Allergan, patents, Restasis
Allergan is dealt another setback as patent board shoots down Mohawk patent deal
Stat
Sat, 02/24/18 - 10:33 pm
Tags:
Allergan, patents
Top drugmakers are counting on two hot drug fields—migraine and NASH—but payers are ready to rumble
Fierce Pharma
Thu, 02/22/18 - 11:28 pm
Tags:
migraines, NASH, Amgen, Eli Lilly, Teva Pharmaceutical, Allergan, Gilead Sciences, Novo Nordisk, Intercept Pharma, PBMs
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
Tags:
AbbVie, Allergan, Roche, Biogen, UCB Pharma, Acorda Therapeutics, M&A
Beat you to it, Purdue. Other opioid makers already ditched promotions
Fierce Pharma
Wed, 02/14/18 - 11:35 am
Tags:
Purdue, opioids, opioid crisis, drug marketing, Teva Pharmaceutical, Janssen, Allergan, Endo International

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.